Soleno Therapeutics, Inc. (SLNO)
52.82
+0.04
(+0.09%)
USD |
NASDAQ |
Apr 30, 16:00
52.78
-0.04
(-0.09%)
After-Hours: 20:00
Soleno Therapeutics Total Liabilities (Quarterly) : 113.72M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.500B |
| Nektar Therapeutics | 190.57M |
| Forian, Inc. | 14.76M |
| Boston Scientific Corp. | -- |
| Integer Holdings Corp. | 1.664B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 563.83M |
| Shareholders Equity (Quarterly) | 450.12M |
| Debt to Equity Ratio | 0.1168 |
| Current Ratio | 5.798 |
| Net Debt Paydown Yield | -0.41% |